Regulators visiting a Roche ($RHHBY) facility in the U.K. found a surprise lurking in the company’s computer system: 80,000 uninvestigated adverse reaction reports from the U.S. The reports are on a hodgepodge of drugs made by the Swiss company and include more than 15,000 reports of deaths, with some of the notices dating back 5 years.
In a statement meant to reassure anyone taking a Roche drug, the European Medicines Agency says there is no evidence of any negative effect on patients, yet, and that no action is needed to be taken by doctors or patients. Roche is the world’s largest maker of cancer drugs.
“The upshot of all this is that governments around the world are flushing billions of dollars down the drain stockpiling a drug that doesn’t work — a drug promoted via propaganda and scientific fraud.”
(NaturalNews) When it comes to selling chemicals that claim to treat H1N1 swine flu, the pharmaceutical industry’s options are limited to two: Vaccines and anti-virals. The most popular anti-viral, by far, is Tamiflu, a drug that’s actually derived from a Traditional Chinese Medicine herb called star anise.
But Tamiflu is no herb. It’s a potentially fatal concentration of isolated chemical components that have essentially been bio-pirated from Chinese medicine. And when you isolate and concentrate specific chemicals in these herbs, you lose the value (and safety) of full-spectrum herbal medicine.
That didn’t stop Tamiflu’s maker, Roche, from trying to find a multi-billion-dollar market for its drug. In order to tap into that market, however, Roche needed to drum up some evidence that Tamiflu was both safe and effective.
Roche engages in science fraud
Roche claims there are ten studies providing Tamiflu is both safe and effective. According to the company, Tamiflu has all sorts of benefits, including a 61% reduction in hospital admissions by people who catch the flu and then get put on Tamiflu.
The problem with these claims is that they aren’t true. They were simply invented by Roche.
A groundbreaking article recently published in the British Medical Journal accuses Roche of misleading governments and physicians over the benefits of Tamiflu. Out of the ten studies cited by Roche, it turns out, only two were ever published in science journals. And where is the original data from those two studies? Lost.
The data has disappeared. Files were discarded. The researcher of one study says he never even saw the data. Roche took care of all that, he explains.
So the Cochrane Collaboration, tasked with reviewing the data behind Tamiflu, decided to investigate. After repeated requests to Roche for the original study data, they remained stonewalled. The only complete data set they received was from an unpublished study of 1,447 adults which showed that Tamiflu was no better than placebo. Data from the studies that claimed Tamiflu was effective was apparently lost forever.
As The Atlantic reports, that’s when former employees of Adis International (essentially a Big Pharma P.R. company) shocked the medical world by announcing they had been hired to ghost-write the studies for Roche.
It gets even better: These researchers were told what to write by Roche!
As one of these ghostwriters told the British Medical Journal:
“The Tamiflu accounts had a list of key messages that you had to get in. It was run by the [Roche] marketing department and you were answerable to them. In the introduction …I had to say what a big problem influenza is. I’d also have to come to the conclusion that Tamiflu was the answer.”
“One of the reasons I have long supported the U.S. biotechnology industry is that it is a homegrown success story that has been an engine of job creation in this country.” This written statement by Rep. Joe Wilson of South Carolina on the health care bill was identical to one by Representative Blaine Luetkemeyer and used language suggested by lobbyists.
WASHINGTON — In the official record of the historic House debate on overhauling health care, the speeches of many lawmakers echo with similarities. Often, that was no accident.
Statements by more than a dozen lawmakers were ghostwritten, in whole or in part, by Washington lobbyists working for Genentech, one of the world’s largest biotechnology companies.
E-mail messages obtained by The New York Times show that the lobbyists drafted one statement for Democrats and another for Republicans.
The lobbyists, employed by Genentech and by two Washington law firms, were remarkably successful in getting the statements printed in the Congressional Record under the names of different members of Congress.
Genentech, a subsidiary of the Swiss drug giant Roche, estimates that 42 House members picked up some of its talking points — 22 Republicans and 20 Democrats, an unusual bipartisan coup for lobbyists.
WASHINGTON — President Barack Obama has declared the swine flu outbreak a national emergency. The White House on Saturday said Obama signed a proclamation that would allow medical officials to bypass certain federal requirements. Officials described the move as similar to a declaration ahead of a hurricane making landfall.
* Disaster proclamation intended as proactive measure
* CDC said swine flu widespread in 46 of 50 states (Adds details on new antiviral drug)
WASHINGTON, Oct 24 (Reuters) – U.S. President Barack Obama has declared 2009 H1N1 swine flu a national emergency, the White House said on Saturday.
The declaration will make it easier for U.S. medical facilities to handle a surge in flu patients by allowing the waiver of some requirements of Medicare, Medicaid and other federal health insurance programs as needed, the White House said in a statement.
The U.S. Centers for Disease Control and Prevention said on Friday that swine flu has become widespread in 46 of the 50 U.S. states, a level comparable to the peak of ordinary flu seasons but far earlier and with more waves of infection expected.
Obama signed the statement on Friday night.
The White House statement said the declaration was intended to prepare the country in case of “a rapid increase in illness that may overburden health care resources.” It was similar to disaster declarations issued before hurricanes hit coastal areas.